ArticleInternal medicine (Tokyo, Japan)2022

Successful Use of Certolizumab Pegol for Refractory Psoriatic Arthritis Triggered by COVID-19 Infection.

Shin-Ichiro Ohmura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.